ethosuximide has been researched along with Connective Tissue Diseases in 1 studies
Ethosuximide: An anticonvulsant especially useful in the treatment of absence seizures unaccompanied by other types of seizures.
ethosuximide : A dicarboximide that is pyrrolidine-2,5-dione in which the hydrogens at position 3 are substituted by one methyl and one ethyl group. An antiepileptic, it is used in the treatment of absence seizures and may be used for myoclonic seizures, but is ineffective against tonic-clonic seizures.
Connective Tissue Diseases: A heterogeneous group of disorders, some hereditary, others acquired, characterized by abnormal structure or function of one or more of the elements of connective tissue, i.e., collagen, elastin, or the mucopolysaccharides.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ethosuximide was halted and due to the severe symptoms, treatment with both prednisolone and intravenous iloprost was commenced." | 5.72 | Severe Raynaud's phenomenon from ethosuximide raised concern over possible onset of systemic vasculitis: a case report. ( Berntson, L; Liminga, G, 2022) |
| "Ethosuximide was halted and due to the severe symptoms, treatment with both prednisolone and intravenous iloprost was commenced." | 1.72 | Severe Raynaud's phenomenon from ethosuximide raised concern over possible onset of systemic vasculitis: a case report. ( Berntson, L; Liminga, G, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berntson, L | 1 |
| Liminga, G | 1 |
1 other study available for ethosuximide and Connective Tissue Diseases
| Article | Year |
|---|---|
Severe Raynaud's phenomenon from ethosuximide raised concern over possible onset of systemic vasculitis: a case report.
Topics: Child; Connective Tissue Diseases; Ethosuximide; Female; Fingers; Humans; Pain; Raynaud Disease; Sys | 2022 |